Related Experiment Video
Updated: Jun 22, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Dexamethasone-induced apoptosis and up-regulation of Bim is dependent on glycogen synthase kinase-3
Ulla Nuutinen1, Antti Ropponen, Sanna Suoranta
1Department of Clinical Microbiology, Institute of Clinical Medicine, University of Kuopio, Yliopistonranta 1 C, 70210 Kuopio, Finland. ulla-maija.nuutinen@uku.fi
Abstract:
Glucocorticoids are commonly used in the treatment of lymphoid malignancies. In this study, we show that apoptosis induced by dexamethasone (Dex), a synthetic glucocorticoid, was dependent on mitochondria, since overexpression of Bcl-X(L) prevented Dex-induced apoptotic changes. Dominant negative (DN) caspase-9 also prevented Dex-induced apoptotic changes including the loss of mitochondrial membrane potential indicating that caspase-9 controls mitochondrial changes. In addition, we evaluated the role of glycogen synthase kinase (GSK3) in Dex-induced apoptosis. Inhibition of GSK3 attenuated Dex-induced up-regulation of Bim, loss of mitochondrial membrane potential, release of cyt c and DNA fragmentation. These results indicate that GSK3 contributes to Dex-induced apoptosis by controlling up-regulation of Bim.
Insights
Dexamethasone-induced apoptosis in lymphoid malignancies relies on mitochondria and caspase-9. Glycogen synthase kinase 3 (GSK3) inhibition blocks this process by controlling Bim, a key protein in apoptosis.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Glucocorticoids, like dexamethasone (Dex), are standard treatments for lymphoid malignancies.
- Understanding the precise mechanisms of glucocorticoid-induced apoptosis is crucial for optimizing cancer therapy.
Purpose of the Study:
- To elucidate the role of mitochondria and specific signaling pathways in dexamethasone-induced apoptosis of lymphoid cells.
- To investigate the involvement of caspase-9 and glycogen synthase kinase 3 (GSK3) in this apoptotic process.
Main Methods:
- Overexpression of Bcl-X(L) to assess mitochondrial dependence.
- Use of dominant-negative (DN) caspase-9 to evaluate caspase-9's role.
- Inhibition of GSK3 to determine its contribution to apoptosis.
Main Results:
- Dexamethasone-induced apoptosis was dependent on mitochondria, as shown by Bcl-X(L) overexpression preventing apoptotic changes.
- DN caspase-9 inhibited Dex-induced apoptosis and mitochondrial membrane potential loss, indicating caspase-9 controls mitochondrial events.
- GSK3 inhibition attenuated Dex-induced Bim up-regulation, mitochondrial dysfunction, cytochrome c release, and DNA fragmentation.
Conclusions:
- Mitochondria and caspase-9 are critical effectors of dexamethasone-induced apoptosis in lymphoid malignancies.
- Glycogen synthase kinase 3 (GSK3) plays a significant role in this process by regulating Bim expression.
Related Concept Videos
The Intrinsic Apoptotic Pathway
TGF - β Signaling Pathway
Caspases
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
cAMP-dependent Protein Kinase Pathways
